Facebook
Twitter
LinkedIn
ForwardPULSE: Winning Hearts: Daptomycin and Ceftaroline for MRSA Endocarditis
Overview
There is a limited number of treatment options available for MRSA bacteremia/endocarditis. Daptomycin in combination with ceftaroline, a novel fifth generation cephalosporin, may be an option for salvage therapy.
Target Audience
Pharmacist
Learning Objectives
- Identify risk factors for MRSA endovascular infections.
- Describe underlying mechanisms associated with combination daptomycin and ceftaroline therapy for MRSA endocarditis.
- Assess clinical data that address the use of daptomycin and ceftaroline for MRSA endocarditis.
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_38.pptx | 461.59 KB |
 Pulse Abstract_BDressman.pdf | 387.62 KB |
Program
There is a limited number of treatment options available for MRSA bacteremia/endocarditis. Daptomycin in combination with ceftaroline, a novel fifth generation cephalosporin, may be an option for salvage therapy.
Venue
Faculty
Benjamin Dressman, PharmD
Accreditation
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.